Related Post
(Trends Wide) — Vaccine advisers to the United States Food and Drug Administration (FDA) voted unanimously on Thursday to recommend the authorization of emergency use of a booster dose of the covid-19 vaccine. by Moderna.
FDA’s Advisory Committee on Vaccines and Related Biologics agreed that a booster dose would be safe and effective for some people six months after completing the primary vaccination schedule.
Moderna had applied for an emergency use authorization to use a half dose of her vaccine as a booster for certain people.
FDA must accept or reject the committee’s recommendation. Next, vaccine advisers from the Centers for Disease Control and Prevention will meet to decide on the recommendations. The meeting is scheduled for October 20.
News in development.
